|
 A genetic test for hereditary melanoma
MELARIS® is a predictive medicine test for inherited susceptibility to melanoma and pancreatic cancer. This test detects inherited mutations in the p16 gene (also called CDKN2A or INK4A), which occur in up to 40% of families with hereditary melanoma. Patient survival is excellent when melanoma is detected at an early stage; however, prognosis is very poor (<15% 5-year survival) when melanoma has spread at the time of diagnosis. Early detection of melanoma is perhaps the best approach to improve outcome.
Please visit the myriadtests.com website to learn more about the melanoma
form of skin cancer.
Related Links
|
